Related Experiment Video
Updated: Apr 28, 2026

14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
26.2K
The aesthetic approach to people with dementia
1Northumbria Healthcare NHS Foundation Trust and Newcastle University, UK
International Psychogeriatrics
|June 14, 2014
Summary
This study explores the ethical approach to dementia care, advocating for an "aesthetic" perspective. It delves into the philosophical understanding of personhood in dementia, guiding how we ought to relate to individuals with this condition.
Area of Science:
- Philosophy of Medicine
- Ethics
- Gerontology
Background:
- Current approaches to dementia care often focus on functional aspects.
- There is a need for a deeper philosophical understanding of personhood in dementia.
- Ethical considerations in dementia care require nuanced perspectives beyond basic virtues.
Purpose of the Study:
- To propose an "aesthetic" approach to interacting with people with dementia.
- To explore the philosophical underpinnings of personhood for individuals with dementia.
- To establish an ethical framework for human relationships with those affected by dementia.
Main Methods:
- Philosophical inquiry and conceptual analysis.
- Ethical reasoning and argumentation.
- Exploration of existential and phenomenological perspectives on personhood.
Main Results:
- The proposed "aesthetic" approach emphasizes a relational understanding of the person with dementia.
- This perspective moves beyond empirical observations to a deeper ethical engagement.
- It redefines our stance as human beings in relation to individuals experiencing dementia.
Conclusions:
- An aesthetic approach offers a profound ethical framework for dementia care.
- Understanding personhood in dementia is crucial for respectful and meaningful interaction.
- This philosophical perspective guides how we ought to relate to individuals with dementia.
Related Concept Videos
Dementia l: Introduction
31
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31
Dementia
685
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
685
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
20
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Documentation in Long-Term and Home Healthcare Setting
1.5K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.5K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

